No insider purchase over the last 90 days. The latest, by Mahai Chris LaVictoire, was filed 20 Jul 2026.
Who traded when
BuySaleSince the insiders bought
- -8.8%Entry US$2.67 · Close at T+90 US$2.44
- -15.7%Entry US$18.57 · Close at T+365 US$15.66
- -5.2%Entry US$15.95 · Close at T+365 US$15.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
- 242.01 shares@ US$19.31810.0006% mcap62.4% of flowCommon StockSEC:0001104659-26-114286:0
- 501 shares@ US$20.960.0013% mcap100.0% of flowCommon StockSEC:0001104659-26-085026:0Canonical exit: 14 Oct 2026 (T+90)
- 1,000 shares@ US$18.88100.0% of flowCommon StockSEC:0001104659-24-080796:0Canonical exit: 14 Oct 2024 (T+90)
- 525 shares@ US$16.4236100.0% of flowCommon StockSEC:0001104659-24-046547:0Canonical exit: 8 Jul 2024 (T+90)
- 170 shares@ US$16.13100.0% of flowCommon stockSEC:0001104659-24-002525:0Canonical exit: 20 Mar 2024 (T+90)
- 1,000 shares@ US$16.929100.0% of flowCommon StockSEC:0001104659-24-001270:0Canonical exit: 1 Apr 2024 (T+90)
- 1,000 shares@ US$16.58100.0% of flowCommon StockSEC:0001104659-24-000357:0Canonical exit: 27 Mar 2024 (T+90)
- 9,500 shares@ US$15.633249.8% of flowShares of Beneficial InterestSEC:0001104659-23-103574:0Canonical exit: 24 Dec 2023 (T+90)
- 9,500 shares@ US$15.876750.2% of flowShares of Beneficial InterestSEC:0001104659-23-102458:0Canonical exit: 19 Dec 2023 (T+90)
- 73.529 shares@ US$20.415812.9% of flowShares of Beneficial InterestSEC:0001104659-22-037466:0Canonical exit: 21 Jun 2022 (T+90)
- 481 shares@ US$21.51587.1% of flowShares of Beneficial InterestSEC:0001104659-22-008200:0Canonical exit: 26 Apr 2022 (T+90)
- 5,200 shares@ US$20.527713.8% of flowShares of Beneficial InterestSEC:0001104659-20-118219:0Canonical exit: 24 Jan 2021 (T+90)
- 5,050 shares@ US$20.678713.5% of flowShares of Beneficial InterestSEC:0001104659-20-116859:0Canonical exit: 19 Jan 2021 (T+90)
- 490 shares@ US$20.39100.0% of flowShares of Beneficial InterestSEC:0001104659-20-107790:0Canonical exit: 22 Dec 2020 (T+90)
- 5,000 shares@ US$21.0114.6% of flowShares of Beneficial InterestSEC:0001104659-20-065198:0Canonical exit: 19 Aug 2020 (T+90)
- 6,800 shares@ US$16.2415.1% of flowShares of Beneficial InterestSEC:0001104659-20-034865:0Canonical exit: 15 Jun 2020 (T+90)
- 6,300 shares@ US$17.1410.3% of flowShares of Beneficial InterestSEC:0001104659-18-074725:0Canonical exit: 26 Mar 2019 (T+90)
- 5,500 shares@ US$20.4310.7% of flowShares of Beneficial InterestSEC:0001104659-18-063922:0Canonical exit: 23 Jan 2019 (T+90)
- 3,882 shares@ US$21.788.0% of flowShares of Beneficial InterestSEC:0001104659-18-062503:0Canonical exit: 15 Jan 2019 (T+90)
- 1,100 shares@ US$24.19100.0% of flowShares of Beneficial InterestSEC:0001728564-18-000005:0Canonical exit: 25 Apr 2018 (T+90)
- 862 shares@ US$28.977100.0% of flowShares of Beneficial InterestSEC:0001104659-16-088608:0Canonical exit: 5 Apr 2016 (T+90)
- 2,000 shares@ US$35.74Shares of Beneficial InterestSEC:0001104659-15-048411:0Canonical exit: 27 Sept 2015 (T+90)
- 745 shares@ US$25.04Shares of Beneficial InterestSEC:0001104659-14-051168:0
- 11,944 shares@ US$25.04Shares of Beneficial InterestSEC:0001104659-14-049752:0
- 77 shares@ US$25.04Shares of Beneficial InterestSEC:0001104659-14-049421:0
25 of 45 declarations
About abrdn Healthcare Investors
Of the 21 filings at abrdn Healthcare Investors, 20 are purchases and just one is a sale: 95% purchases among open-market trades. The 20 purchases total EUR 1,052,659, with a median of EUR 22,353, and the sale, EUR 4,163, is Alan R. Goodson's, Director, on October 6, 2026.
Daniel R. Omstead, President, files 9 of these, all purchases. The largest amounts are EUR 141,583 on September 20, 2023, EUR 140,219 on September 25, 2023 and EUR 98,925 on March 17, 2020. Kathleen Goetz, Director, adds 3 purchases, and Chris LaVictoire Mahai and Rose DiMartino, also Directors, 1 each. From December 21, 2023 to January 2, 2024, 3 filers bought for EUR 32,766. Across the full history, 3 purchase filings are classed as clustered.
Read moreShow less
Listed on Nasdaq with a market value of USD 1.1 billion, the entity has filings published between January 7, 2016 and October 7, 2026, with peaks in 2020 and 2024 (5 each). They appear the day after the trade, in median (1 day). For 19 purchases the stored 90-day return has a median of 0.7%, with 58% of cases positive: recorded past results, not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
